MedPath

Olmat- AMH

Brand Name: Olmat- AMH

Generic Name: Olmesartan Medoxomil + Amlodipine + Hydrochlorothiazide

Active
Registration Number

DR-XY48153

Dosage Form

Tablets

Issuance Date

July 1, 2022

Expiry Date

July 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength40 mg/10 mg/25 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antihypertensive (Angiotensin II Receptor Blocker/ Calcium Channel Blocker/ Diuretic)
A
Application
Monitored Release
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

Olmesartan MedoxomilActive
Monograph: Olmesartan
AmlodipineActive
Monograph: Amlodipine
HydrochlorothiazideActive

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform